Cell Biotech Co., Ltd. (KOSDAQ:049960)
16,200
-20 (-0.12%)
At close: Apr 28, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 111.08 billion as of April 29, 2026. Its market cap has increased by 30.68% in one year.
Market Cap
111.08B
Enterprise Value
18.44B
Revenue
53.13B
Ranking
n/a
PE Ratio
10.97
Stock Price
16,200.00
Market Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 111.08B, an increase of 695.22%. That is a compound annual growth rate of 9.36%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 103.50B |
| TegoScience | 103.20B |
| NovMetaPharma | 121.99B |
| CHA Vaccine Research Institute | 100.21B |
| SunBio,Inc. | 98.77B |
| BIO-FD&C | 125.65B |
| CTCBIO | 94.92B |
| Choong Ang Vaccine Laboratory | 92.98B |